This website will be unavailable from Friday, April 26, 2024 at 6:00 p.m. through Monday, April 29, 2024 at 7:00 a.m. due to data center maintenance.

 
 
  By: Paxton S.B. No. 1780
 
 
A BILL TO BE ENTITLED
 
AN ACT
  relating to value-based arrangements in the Medicaid vendor drug
  program.
         BE IT ENACTED BY THE LEGISLATURE OF THE STATE OF TEXAS:
         SECTION 1.  Subchapter B, Chapter 531, Government Code, is
  amended by adding Section 531.0701 to read as follows:
         Sec. 531.0701.  VALUE-BASED ARRANGEMENTS. (a)  In this
  section, "manufacturer" has the meaning assigned by Section
  531.070.
         (b)  Subject to Section 531.071, the commission may enter
  into a value-based arrangement for the Medicaid vendor drug program
  by written agreement with a manufacturer based on outcome data or
  other metrics to which this state and the manufacturer agree in
  writing.  The value-based arrangement may include a rebate, a
  discount, a price reduction, a contribution, risk sharing, a
  reimbursement, payment deferral or installment payments, a
  guarantee, patient care, shared savings payments, withholds, a
  bonus, or any other thing of value.
         SECTION 2.  If before implementing any provision of this Act
  a state agency determines that a waiver or authorization from a
  federal agency is necessary for implementation of that provision,
  the agency affected by the provision shall request the waiver or
  authorization and may delay implementing that provision until the
  waiver or authorization is granted.
         SECTION 3.  The Health and Human Services Commission is
  required to implement a provision of this Act only if the
  legislature appropriates money specifically for that purpose.  If
  the legislature does not appropriate money specifically for that
  purpose, the commission may, but is not required to, implement a
  provision of this Act using other appropriations available for that
  purpose.
         SECTION 4.  This Act takes effect September 1, 2019.